These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7548777)
1. Pharmacokinetics of methotrexate after intravenous and intramuscular injection of methotrexate-bearing positively charged liposomes to rats. Kim MM; Lee SH; Lee MG; Hwang SJ; Kim CK Biopharm Drug Dispos; 1995 May; 16(4):279-93. PubMed ID: 7548777 [TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of methotrexate after intravenous administration of methotrexate-loaded proliposomes to rats. Park JM; Ahn BN; Yoon EJ; Lee MG; Shim CK; Kim CK Biopharm Drug Dispos; 1994 Jul; 15(5):391-407. PubMed ID: 7981428 [TBL] [Abstract][Full Text] [Related]
3. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. Kim CK; Han JH J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration. Chen ML; Chiou WL J Pharmacokinet Biopharm; 1983 Oct; 11(5):499-513. PubMed ID: 6668556 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats. Yoon WH; Park SJ; Kim IC; Lee MG Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757 [TBL] [Abstract][Full Text] [Related]
6. Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers. Yuan SH; Ge WH; Huo J; Wang XH Fundam Clin Pharmacol; 2009 Apr; 23(2):189-96. PubMed ID: 19298236 [TBL] [Abstract][Full Text] [Related]
7. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine. Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic changes of methotrexate after intravenous administration to uranyl nitrate-induced acute renal failure rats. Park JM; Moon CH; Lee MG Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):353-62. PubMed ID: 8896046 [TBL] [Abstract][Full Text] [Related]
9. Enhanced systemic availability of methotrexate in the presence of morin in rats. Hong SS; Jin MJ; Han HK Biopharm Drug Dispos; 2008 May; 29(4):189-93. PubMed ID: 18240155 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of low doses of methotrexate in patients with psoriasis over the early period of treatment. Chládek J; Martínková J; Simková M; Vanecková J; Koudelková V; Nozicková M Eur J Clin Pharmacol; 1998 Feb; 53(6):437-44. PubMed ID: 9551702 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic study of methotrexate following intra-articular injection of methotrexate loaded poly(L-lactic acid) microspheres in rabbits. Liang LS; Wong W; Burt HM J Pharm Sci; 2005 Jun; 94(6):1204-15. PubMed ID: 15858840 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of four metabolites of DA-125, a new anthracycline antineoplastic agent after single and multiple intravenous administration to rats. Lee SD; Lee WI; Shim HJ; Lee ED; Kim WB; Yang J; Kim CK; Lee MG J Clin Pharm Ther; 1996 Aug; 21(4):201-13. PubMed ID: 8933293 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of methotrexate in the extracellular fluid of brain C6-glioma after intravenous infusion in rats. Dukic S; Heurtaux T; Kaltenbach ML; Hoizey G; Lallemand A; Gourdier B; Vistelle R Pharm Res; 1999 Aug; 16(8):1219-25. PubMed ID: 10468023 [TBL] [Abstract][Full Text] [Related]
14. Influence of piperacillin on the pharmacokinetics of methotrexate and 7-hydroxymethotrexate. Najjar TA; Abou-Auda HS; Ghilzai NM Cancer Chemother Pharmacol; 1998; 42(5):423-8. PubMed ID: 9771959 [TBL] [Abstract][Full Text] [Related]
15. [PEGylated polyamidoamine dendrimer/methotrexate complex: pharmacokinetics and anti-tumor activity in normal and tumor-bearing rodents]. Kong SY; Tang GT; Pei YY; Jiang YY Yao Xue Xue Bao; 2009 Jan; 44(1):85-90. PubMed ID: 19350828 [TBL] [Abstract][Full Text] [Related]
16. The effect of entrapment in liposomes on the in vivo distribution of [3H]methotrexate in a primate. Kimelberg HK; Tracy TF; Biddlecome SM; Bourke RS Cancer Res; 1976 Aug; 36(8):2949-57. PubMed ID: 819137 [TBL] [Abstract][Full Text] [Related]
17. Prolonged blood circulation of methotrexate by modulation of liposomal composition. Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781 [TBL] [Abstract][Full Text] [Related]
18. Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion. Chen ML; Chiou WL J Pharmacokinet Biopharm; 1983 Oct; 11(5):515-27. PubMed ID: 6668557 [TBL] [Abstract][Full Text] [Related]
19. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate. Chládková J; Hak J; Martínková J; Chládek J Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469 [TBL] [Abstract][Full Text] [Related]
20. Treatment of unruptured tubal pregnancy with methotrexate: pharmacokinetic analysis of local versus intramuscular administration. Fernandez H; Bourget P; Ville Y; Lelaidier C; Frydman R Fertil Steril; 1994 Nov; 62(5):943-7. PubMed ID: 7926139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]